Literature DB >> 9698340

Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors.

P De Deurwaerdère1, L Stinus, U Spampinato.   

Abstract

In the present study we investigate, using in vivo microdialysis, the involvement of central 5-HT3 receptors in the effect of dorsal raphe nucleus (DRN) electrical stimulation on dopamine (DA), 3, 4-dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindole-3-acetic acid (5-HIAA) extracellular levels monitored in the nucleus accumbens and the striatum of halothane-anesthetized rats. DRN stimulation (300 microA, 1 msec at 3, 5, 10, and 20 Hz for 15 min) induced a frequency-dependent increase of accumbal DA release and a concomitant reduction of DA release in the ipsilateral striatum at 20 Hz. In both structures DOPAC and 5-HIAA dialysate contents were enhanced in a frequency-dependent manner. Central serotonin (5-HT) depletion, induced by intra-raphe injections of 5, 7-dihydroxytryptamine neurotoxin, abolished the effect of 20 Hz DRN stimulation on DA, DOPAC, and 5-HIAA extracellular levels in both regions. The 5-HT synthesis inhibitor para-chlorophenylalanine (3 x 400 mg/kg, i.p., for 3 d), although preventing the effect on DA release, failed to modify significantly the effect of 20 Hz DRN stimulation on DOPAC and 5-HIAA outflow in both structures. Ondansetron (0.1 and 1 mg/kg) and (S)-zacopride (0.1 mg/kg), two 5-HT3 antagonists, significantly impaired the increase of accumbal DA release induced by 20 Hz DRN stimulation but did not affect either the decrease of striatal DA release or the increase in DOPAC outflow in both structures. These results indicate that an enhancement of central 5-HT transmission induced by DRN stimulation differentially affects striatal and accumbal DA release and that endogenous 5-HT, via its action on 5-HT3 receptors, exerts a facilitatory control restricted to the mesoaccumbal DA pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9698340      PMCID: PMC6793211     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

Review 1.  Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

Authors:  A Y Deutch; B Moghaddam; R B Innis; J H Krystal; G K Aghajanian; B S Bunney; D S Charney
Journal:  Schizophr Res       Date:  1991 Mar-Apr       Impact factor: 4.939

2.  Dorsal raphé stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo.

Authors:  F Trent; J M Tepper
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

3.  A comparison of biochemical indices of 5-hydroxytryptaminergic neuronal activity following electrical stimulation of the dorsal raphe nucleus.

Authors:  N J Shannon; J W Gunnet; K E Moore
Journal:  J Neurochem       Date:  1986-09       Impact factor: 5.372

4.  5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice.

Authors:  M E Reith
Journal:  Eur J Pharmacol       Date:  1990-09-21       Impact factor: 4.432

Review 5.  The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine systems.

Authors:  M D Tricklebank
Journal:  Behav Brain Res       Date:  1996       Impact factor: 3.332

6.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat.

Authors:  E C Azmitia; M Segal
Journal:  J Comp Neurol       Date:  1978-06-01       Impact factor: 3.215

Review 7.  Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential.

Authors:  A J Greenshaw
Journal:  Trends Pharmacol Sci       Date:  1993-07       Impact factor: 14.819

8.  Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat.

Authors:  K Yoshimoto; W J McBride
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

Review 9.  Serotonin-dopamine interaction and its relevance to schizophrenia.

Authors:  S Kapur; G Remington
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

10.  Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release.

Authors:  E Carboni; E Acquas; R Frau; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1989-05-30       Impact factor: 4.432

View more
  22 in total

Review 1.  REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.

Authors:  Philippe H Robert; Emmanuel Mulin; Patrick Malléa; Renaud David
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

Review 2.  Modulation of ligand-gated ion channels by antidepressants and antipsychotics.

Authors:  Gerhard Rammes; Rainer Rupprecht
Journal:  Mol Neurobiol       Date:  2007-04       Impact factor: 5.590

3.  Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity.

Authors:  P Brown; M E Molliver
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

4.  The effects of a single exposure to uncontrollable stress on the subsequent conditioned place preference responses to oxycodone, cocaine, and ethanol in rats.

Authors:  Andre Der-Avakian; Sondra T Bland; Robert R Rozeske; Julie P Tamblyn; Mark R Hutchinson; Linda R Watkins; Steven F Maier
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

5.  The effects of a single session of inescapable tailshock on the subsequent locomotor response to brief footshock and cocaine administration in rats.

Authors:  Andre Der-Avakian; Robert R Rozeske; Sondra T Bland; Linda R Watkins; Steven F Maier
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

Review 6.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

7.  Forebrain GABAergic projections from the dorsal raphe nucleus identified by using GAD67-GFP knock-in mice.

Authors:  Sun Jung Bang; Kathryn G Commons
Journal:  J Comp Neurol       Date:  2012-12-15       Impact factor: 3.215

8.  Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.

Authors:  S Body; K Asgari; J F Rickard; Z Zhang; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

9.  Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice.

Authors:  Stéphane Doly; Jesus Bertran-Gonzalez; Jacques Callebert; Alexandra Bruneau; Sophie Marie Banas; Arnauld Belmer; Katia Boutourlinsky; Denis Hervé; Jean-Marie Launay; Luc Maroteaux
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

10.  Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

Authors:  Mark J Millan; Sylvie Veiga; Sylvie Girardon; Mauricette Brocco
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.